来自专业的译者、企业、网页和免费的翻译库。
mast cell tumours are cancerous proliferations of mast cells.
it-tumuri tal-mast cell huma proliferazzjonijiet kanċerużi tal-mast cells.
最后更新: 2017-04-26
使用频率: 3
质量:
masivet is a prescription medicine used to treat dog mast cell tumours.
masivet huwa mediċina bir-riċetta li tintuża għat-trattament ta’ tumuri tal-mast cell fil-klieb.
最后更新: 2017-04-26
使用频率: 3
质量:
in certain circumstances, mast cell tumours can be life threatening for your dog.
f’ċerti ċirkustanzi, it-tumuri tal-mast cell jistgħu jkunu ta’ theddida għall-ħajja tal-kelb tiegħek.
最后更新: 2017-04-26
使用频率: 3
质量:
the main study was carried out in two phases in 151 dogs with mast cell tumours.
l-istudju prinċipali sar f’żewġ fażijiet fuq 151 kelb bit-tumuri tat-tip mast-cell.
最后更新: 2017-04-26
使用频率: 1
质量:
canine mast cell tumour growth is frequently driven by an activating mutation in c-kit.
tumuri mast cell fil-klieb jikbru ta’ spiss minħabba mutazzjoni li tattiva is-c-kit.
最后更新: 2017-04-26
使用频率: 1
质量:
there was no evidence of an anaphylactic response due to mast-cell degranulation in cynomolgus monkeys.
ma kienx hemm evidenza ta’ rispons anafilattiku permezz ta’ degranulazzjoni ta’ ċelluli tat-tip mast fix-xadini cynomolgus.
最后更新: 2017-04-26
使用频率: 3
质量:
palladia is used to treat dogs with mast-cell tumours (a type of skin cancer).
palladia jintuża sabiex jittratta klieb b’tumuri tat-tip mast-cell (tip ta’ kanċer tal-ġilda).
最后更新: 2017-04-26
使用频率: 1
质量:
en 1495:1997lifting platforms – mast climbing work platforms
en 1495:1997lifting platforms — mast climbing work platforms(il-pjattaformi ta’ l-irfigħ – pjattaformi taxxogħol xabbata ta’ larbli)
最后更新: 2014-02-06
使用频率: 1
质量:
if gastrointestinal ulceration is suspected, whether or not due to palladia or to mast cell tumour degranulation, stop the administration of palladia and treat appropriately.
jekk hemm suspett ta’ ulċera gastro- intestinali, kemm jekk minħabba palladia jew minħabba mast cell tumour degranulation, waqqaf l- amministrazzjoni ta’ palladia u agħti t-trattament li jkun hemm bżonn.
最后更新: 2017-04-26
使用频率: 1
质量:
masitinib treatment should only be used in dogs with non-resectable mast cell tumours and which express the mutated c-kit tyrosine kinase receptor.
it-trattament b’masitinib għandu jintuża biss fi klieb li jkollhom tumuri tal-mast cell li ma jkunux jistgħu jitneħħew u li jesprimu r-riċettur mibdul tal-c-kit tyrosine kinase.
最后更新: 2017-04-26
使用频率: 3
质量:
some types of mast-cell tumour are linked to a mutation that causes excessive action of c-kit and stimulates the mast cells to divide uncontrollably.
xi tipi ta’ tumur taċ-ċelluli-mast huma marbutin ma’ tibdil ġenetiku li jikkaġuna azzjoni eċċessiva ta’ c-kit u jistimula liċ-ċelluli mast biex jinqasmu mingħajr kontroll.
最后更新: 2017-04-26
使用频率: 3
质量:
treatment of non-resectable dog mast cell tumours (grade 2 or 3) with confirmed mutated c-kit tyrosine kinase receptor.
trattament ta’ tumuri tal-mast cell (grad 2 jew 3) fil-klieb u li ma jistgħux jitneħħew, b’riċettur mibdul ikkonfermat tal-c-kit tyrosine kinase.
最后更新: 2017-04-26
使用频率: 3
质量:
data from in vitro studies suggest that it may act on human conjunctival mast cells to inhibit the release of pro-inflammatory mediators.
minn tagħrif ta 'studji in vitro jidher li jista ’ jaħdem fuq iċ- ċelluli mast tal- konġuntiva umana biex jinibixxi sustanzi pro- infjammatorji.
最后更新: 2011-10-23
使用频率: 1
质量:
警告:此对齐可能有误。
如果您觉得是这样,请将其删除。
masivet is for the treatment of dogs with non-resectable mast cell tumours (grade 2 or 3) with a confirmed mutated c-kit tyrosine kinase receptor.
masivet jintuża għat-trattament ta’ klieb li jkollhom tumuri tal-mast cell (grad 2 jew 3) li ma jistgħux jitneħħew, b’riċettur mibdul ikkonfermat tal-c-kit tyrosine kinase.
最后更新: 2017-04-26
使用频率: 3
质量:
iron or steel towers and lattice masts
torrijiet tal-ħadid jew l-azzar u arbli tal-kannizzati
最后更新: 2014-11-21
使用频率: 4
质量:
一些相关性较低的人工翻译已被隐藏。
显示低相关性结果。